Though the recent UNICEF report on child mortality shows progress is being made in every region to prevent childhood deaths, “it is clear that we still need to increase the coverage of high-impact, low-cost interventions like vaccines, including those for pneumonia and diarrhea that are rolling out,” Melinda Gates, co-chair of…
“After a decade of unprecedented increases in donor funding and a corresponding 17 percent decline worldwide in the number of new infections, the fight against HIV is losing momentum,” Bjorn Lomborg, director of the Copenhagen Consensus Center and an adjunct professor at Copenhagen Business School, and Peter Piot, director of the London School of Hygiene and Tropical Medicine and former executive director of UNAIDS, write in this Wall Street Journal opinion piece.
Arjen Dondorp, deputy director of the Mahidol Oxford Tropical Research Unit at Mahidol University in Bangkok, Thailand, and colleagues discuss the need to combat antimalarial drug resistance in this New England Journal of Medicine opinion piece, writing, “Researchers, funders, and policy leaders must recognize the urgency of the problem, take action to address simultaneously several important knowledge gaps, and focus immediately on eliminating the threat of artemisinin resistance.”
In this opinion piece in The Hill’s “Congress Blog,” Rep. Barbara Lee (D-Calif) writes that cutting “funding of vital programs that focus on global food security, health, climate adaptation, and disaster relief, … which make up less than one percent of the U.S. federal budget, will not get us far in terms of plugging the budget gap but they could literally make the difference between life and death for many of the worldâ€™s poor.” She adds, “As part of a global response, the U.S. is responding, having already provided more than $600 million in assistance. … To ensure that future droughts donâ€™t again devastate poor and vulnerable communities, we must support investments in small scale food producers, especially women, to increase agricultural productivity and build resilience,” (9/21).
The health care system in the refugee camps in Dadaab, Kenya, which were established “long ago,” are “currently challenged and stretched by the recent influx of refugees,” UNFPA Executive Director Babatunde Osotimihen writes in this BMJ Group Blogs entry, noting that efforts are underway “to strengthen the existing system with supplies [and] human resources at clinic and outreach levels” to increase access. UNFPA is working “to improve reproductive health care in Dadaab and in accessible parts of Somalia through the provision of related life-saving medical supplies and equipment, which will lead to a reduction in adult and child morbidity and death,” he writes.
Mary Fanning, South Africa’s country coordinator for PEPFAR, writes in a New Age guest column, “In the fight against HIV/AIDS, this is a time of hope. It’s also a time to celebrate the partnerships that are advancing this work and to recommit to a plan to ensure prevention, treatment and care for those infected and affected is sustainable and locally managed,” adding, “Ultimately, whether it’s putting more people on treatment, supporting HIV testing campaigns or leveraging mass media to drive the prevention message, the partnership between the U.S. and South African governments saves lives.”
Nobel Peace Prize winner and human rights advocate Archbishop Desmond Tutu writes in a Washington Post opinion piece that President Barack Obama “is in a position to make a game-changing impact on the war against AIDS” and he “should lead the world in a massive effort to expand access to treatment and rid humanity of AIDS — the most devastating disease of our time.” However, “just as the end of AIDS has finally come within reach, we are witnessing an unprecedented drop in financial and political support for the cause,” he adds.
Recent U.N. statistics showing a drop in child mortality are both good and bad, because the number of child deaths continues to drop, but “progress isn’t reaching all families around the world, and it isn’t reaching newborn babies as often as older children,” Joy Lawn, director of Global Evidence and Policy for Save the Children’s Saving Newborn Lives program, writes in a GlobalPost opinion piece. While the knowledge and technology exist to save lives, “too often, there is simply no one equipped to deliver basic lifesaving care to families who need it most. More than anything else, babies and children die for lack of frontline health workers,” she writes.
“[F]ar too many children in Kenya and other African countries continue to suffer unnecessarily each year due to the misdiagnosis of fever, which contributes to the deaths of nearly three million children of less than five years of age from malaria and pneumonia,” Willis Akhwale, head of Kenya’s Department of Disease Prevention and Control in the Ministry of Public Health and Sanitation, writes in a Daily Nation opinion piece, saying that health care workers “desperately need a test that can quickly and accurately identify and distinguish between fever-causing diseases.”
Some of the issues to be addressed at the U.N. High-level Meeting on Non-Communicable Diseases (NCDs) taking place this week in New York “are controversial, including those relating to intellectual property rights for new medicines, diagnostics and medical devices,” James Love, director of Knowledge Ecology International, writes in an Al Jazeera opinion piece. “By continuing to assert that the Doha Declaration is in fact limited in various ways, U.S. and European trade negotiators have tried to discourage the granting of compulsory licenses on patents for high-priced drugs for cancer and other non-communicable diseases,” he continues, before outlining a proposal called the “cancer prize approach” that would de-link drug prices from research and development incentives.